Reshma Kewalramani, CEO and president at Vertex, said, in the press release, “I’m pleased that NHS England has recognized the value of KAFTRIO, and that Vertex and NHS England have been able to work ...

Vertex remains actively involved in reimbursement discussions in many other countries to make ORKAMBI available to all people who can benefit from this important medicine.